Bionano Genomics Inc (BNGO)
0.4596
+0.02
(+4.69%)
USD |
NASDAQ |
Oct 04, 16:00
0.4505
-0.01
(-1.98%)
After-Hours: 20:00
Bionano Genomics Shareholders Equity (Annual): 96.16M for Dec. 31, 2023
Shareholders Equity (Annual) Chart
Historical Shareholders Equity (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 96.16M |
| December 31, 2022 | 249.40M |
| December 31, 2021 | 337.12M |
| December 31, 2020 | 35.08M |
| Date | Value |
|---|---|
| December 31, 2019 | 3.614M |
| December 31, 2018 | 10.14M |
| December 31, 2017 | -50.23M |
| December 31, 2016 | -27.26M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Annual) Range, Past 5 Years
3.614M
Minimum
2019
337.12M
Maximum
2021
144.27M
Average
96.16M
Median
2023
Shareholders Equity (Annual) Benchmarks
| Revvity Inc | 7.873B |
| Bruker Corp | 1.377B |
| Azenta Inc | 2.534B |
| Harvard Bioscience Inc | 73.07M |
| Akoya Biosciences Inc | 53.77M |